Lilly's weight-loss pill meets main goal in late-stage sleep apnea study

Lilly's weight-loss pill meets main goal in late-stage sleep apnea study

来源:Reuters发布于 2026-11-09

Eli Lilly said on ​Monday its oral weight-loss ‌drug Foundayo significantly reduced breathing interruptions during ​sleep in obese ​adults with moderate-to-severe obstructive sleep ⁠apnea, meeting the...

相关标的:LLY

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。